Evolus, Inc. Note Agreements
3 Contracts & Agreements
- Convertible Promissory Note Conversion Agreement, dated March 23, 2021, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on May 12, 2021)
- Convertible Promissory Note Purchase Agreement, dated July 6, 2020, by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on July 7, 2020)
- Form of Convertible Promissory Note by and between Evolus, Inc. and Daewoong Pharmaceutical Co. Ltd (Filed With SEC on July 7, 2020)
